Norann Zaghloul, Ph.D.
Responsibilities & Activities
My primary interest is in understanding the genetic underpinnings of type 2 diabetes and related metabolic disorders. My portfolios include projects in genetics and genomics of T2D which seek to identify genes and pathways contributing to T2D and its complications. I am also responsible for projects related to functional genomic modeling of T2D and metabolic disorders in model organisms, including mammalian and non-mammalian systems.
I also serve as the Co-Chair and Program Officer for the Accelerating Medicines Partnership® program for Common Metabolic Diseases (AMP CMD).
Accelerating Medicines Partnership® Program for Common Metabolic Diseases (AMP® CMD)
A collaborative partnership between the NIDDK, FNIH, pharmaceutical companies, and nonprofit organizations to develop new models for identifying and validating promising biological targets to serve as biomarkers and/or for drug discovery.
Diabetes Genetics & Genomics
Genetic mechanisms underlying type 1 and type 2 diabetes and how genetic and epigenetic variation influences the metabolism of therapeutics.
Assistant/Associate Professor, Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, 2010-2019
Postdoctoral Fellow, Institute of Genetic Medicine, The Johns Hopkins University, 2006-2010
Ph.D., Genetics, The George Washington University, 2006